Evolva reaches milestone in BASF collaboration
31-Jan-2013
- Switzerland
Evolva Holding SA announced that it has achieved a key milestone in its collaboration with BASF. The collaboration involves joint research on the design of novel and optimised biosynthetic routes for a natural product with crop protection potential.
Evolva has produced a yeast strain that achieves a fermentation yield that exceeds the project requirement. Based on this achievement, BASF has made a low six-digit Swiss Franc milestone payment to Evolva.
Evolva will be entitled to receive royalties on sales of any future product, resulting from this collaboration.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Microchip detects vaccination gaps - A new microchip tests for antibodies against corona, measles, diphtheria and tetanus in parallel - with a single drop of blood
15 emerging technologies that could reduce global catastrophic biological risks
Rambutan
Seeing inside cells with an integrated nanowire probe - Real-time, in-situ sensing and tracking of cell development and maturation is achieved using a label-free nano-optical device
Deciphering how CD4 T cells die during HIV infection
The BioInnovation Institute supports three international start-ups developing pioneering science in the therapeutics and health tech space
Seed_company
Research_on_Adverse_Drug_events_And_Reports
Pharmocogenomics has not fulfilled its promise - Little research on the treatment of rare and orphan diseases has been conducted in developing countries
